Show Summary Details
- Title Pages
- [UNTITLED]
- Contributors
- Foreword
- Introduction
-
Chapter 1 Overview of HIV Prevention Programs in Developing Countries -
Chapter 2 Implications of Economic Evaluations for National HIV Prevention Policy Makers -
Chapter 3 Statistical Issues in HIV Prevention -
Chapter 4 Epidemiological Issues in the Evaluation of HIV Prevention Programs -
Chapter 5 Difficult Choices, Urgent Needs: Optimal Investment in HIV Prevention Programs -
Chapter 6 Methadone Treatment as HIV Prevention: Cost-Effectiveness Analysis -
Chapter 7 Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use -
Chapter 8 Harm Reduction in Rome: A Model-Based Evaluation of Its Impact on the HIV-1 Epidemic -
Chapter 9 Evaluating Israel's Ethiopian Blood Ban -
Chapter 10 Feeding Strategies for Children of HIV-Infected Mothers: Modeling the Trade-Off Between HIV Infection and Non-HIV Mortality -
Chapter 11 Design of HIV Trials for Estimating External Effects -
Chapter 12 Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines -
Chapter 13 Health Policy Modeling: Epidemic Control, HIV Vaccines, and Risky Behavior -
Chapter 14 Development and Validation of a Serologic Testing Algorithm for Recent HIV Seroconversion -
Chapter 15 Issues in Quantitative Evaluation of Epidemiologic Evidence for Temporal Variability of HIV Infectivity - Index
(p.ix) Foreword
(p.ix) Foreword
- Source:
- Quantitative Evaluation of HIV Prevention Programs
- Publisher:
- Yale University Press
Yale Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.
- Title Pages
- [UNTITLED]
- Contributors
- Foreword
- Introduction
-
Chapter 1 Overview of HIV Prevention Programs in Developing Countries -
Chapter 2 Implications of Economic Evaluations for National HIV Prevention Policy Makers -
Chapter 3 Statistical Issues in HIV Prevention -
Chapter 4 Epidemiological Issues in the Evaluation of HIV Prevention Programs -
Chapter 5 Difficult Choices, Urgent Needs: Optimal Investment in HIV Prevention Programs -
Chapter 6 Methadone Treatment as HIV Prevention: Cost-Effectiveness Analysis -
Chapter 7 Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use -
Chapter 8 Harm Reduction in Rome: A Model-Based Evaluation of Its Impact on the HIV-1 Epidemic -
Chapter 9 Evaluating Israel's Ethiopian Blood Ban -
Chapter 10 Feeding Strategies for Children of HIV-Infected Mothers: Modeling the Trade-Off Between HIV Infection and Non-HIV Mortality -
Chapter 11 Design of HIV Trials for Estimating External Effects -
Chapter 12 Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines -
Chapter 13 Health Policy Modeling: Epidemic Control, HIV Vaccines, and Risky Behavior -
Chapter 14 Development and Validation of a Serologic Testing Algorithm for Recent HIV Seroconversion -
Chapter 15 Issues in Quantitative Evaluation of Epidemiologic Evidence for Temporal Variability of HIV Infectivity - Index
